POLR1H and hepatocellular carcinoma: Subgroup analysis showed that HCC patients with high ZNDR1 expression had significant lower OS and DFS than those with low ZNRD1 expression both in early (stages I and II) and late‐stage (stages III and IV) patients (Figure 2J,K), indicating that upregulated ZNDR1 might be a potential prognostic biomarker besides TNM stage.